Detalles de la búsqueda
1.
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis.
Lancet Oncol
; 24(11): 1277-1286, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922931
2.
Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'.
Acta Oncol
; 61(6): 663-668, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35481400
3.
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Eur J Cancer
; 156: 12-23, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34392187
4.
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Eur J Cancer
; 134: 62-74, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32470848
5.
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.
Eur J Cancer
; 94: 156-167, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567632
6.
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Lancet Respir Med
; 6(6): 431-441, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669701
7.
Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial.
Eur J Cancer
; 75: 33-40, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214655
8.
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial.
Eur J Cancer
; 109: 192-195, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655100
Resultados
1 -
8
de 8
1
Próxima >
>>